Quince TherapeuticsQNCX 13F holders, Q2 2026 (June 30) 26 holders
1 famous investor
$52.43 avg. 13F price*
At the end of Q2 2026 , 26 institutions reported holding Quince Therapeutics Inc. (QNCX) in their 13F filings. The largest holders were Balyasny Asset Management L.P. ($12.6M), Ikarian Capital, LLC ($1.3M) and Millennium Management ($1.3M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
Company Quince Therapeutics Inc.
CUSIP 22053A305
Latest filing quarter Q2 2026
Total Exit/New Position Q2 2026 Institutions Total Value New Positions 26 $17.3M Exits 0 $0
Ownership 26 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Balyasny Asset Management L.P. 0.02% New 69,967 $12.6M Ikarian Capital, LLC 0.22% New 72,251 $1.3M Millennium Management 0.00% New 70,779 $1.3M Squadron Capital Management LLC 0.25% New 40,375 $734K Shay Capital LLC 0.04% New 17,468 $329K Boothbay Fund Management, LLC 0.01% New 13,911 $253K Jane Street Group, LLC 0.00% New 12,642 $230K Vanguard Capital Management LLC 0.00% New 12,044 $219K Cormorant Asset Management, LP 0.01% New 5,498 $100K UBS Group AG 0.00% New 4,730 $86K Morgan Stanley 0.00% New 4,084 $74K Vanguard Fiduciary Trust Co. 0.00% New 3,614 $66K BlackRock, Inc. 0.00% New 1,702 $31K Tower Research Capital LLC (TRC) 0.00% New 567 $10K Gen-Wealth Partners Inc 0.00% New 165 $3K Operose Advisors LLC 0.00% New 159 $3K Fortitude Family Office, LLC 0.00% New 40 $728 Barclays PLC 0.00% New 27 $491 Wells Fargo & Company 0.00% New 10 $182 Allworth Financial LP 0.00% New 8 $137 Parallel Advisors, LLC 0.00% New 3 $55 Westside Investment Management, Inc. 0.00% New 1 $18 Steward Partners Investment Advisory, LLC 0.00% New 1 $18 JDM Financial Group LLC 0.00% New 1 $18 JPMorgan Chase & Co. 0.00% New 2 $2 Royal Bank of Canada 0.00% New 1 $0
"% of holder's portfolio" is QNCX's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.